Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Professor Ian Phillips to Speak at Orphan Drugs Research & Commercialization Conference May 8-10 in Boston - Professor M. Ian Phillips will present about gene and stem cell therapies at the Inaugural Orphan Drugs Research and Commercialization Conference, held May 8-10, 2013 in Boston, MA by GTC - GTCbio.com
Professor Ian Phillips to Speak at Orphan Drugs Research & Commercialization Conference May 8-10 in Boston

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2013/01/28 - Professor M. Ian Phillips will present about gene and stem cell therapies at the Inaugural Orphan Drugs Research and Commercialization Conference, held May 8-10, 2013 in Boston, MA by GTC - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Professor M. Ian Phillips, Norris Life Professor and Director of the Center for Rare Disease Therapies at the Keck Graduate Institute, will present about gene and stem cell therapies at the Inaugural Orphan Drugs Research and Commercialization Conference, held May 8-10, 2013 in Boston, MA by GTC.

Nearly 400 new orphan drugs have been approved for marketing since the Orphan Drug Act of 1983. Despite this, currently only 5% of the approximately 7,000 rare diseases have therapies. The advanced platforms of gene therapy and stem cell therapy, or a combination of both, offer new approaches to cell therapies for rare intractable diseases that are currently untreatable. Gene therapy is for repairing dysfunctional cells, while stem cell therapy is for regenerating functional cells.

Gene therapies involve the correction of defective genes by the use of viral vectors. Adeno-associated virus and lentivirus are dominating the field. They are being tested for the treatment of diseases caused by the failure of a single gene, in cystic fibrosis, various forms of blindness, hemophilia, lipase protein deficiency, adrenoleukodystrophy and other autoimmune diseases. In theory, if the dysfunctional gene is replaced with the correct healthy gene, a cure can be achieved. This raises questions of how much to charge for a one shot treatment that can cure a disease, and who will pay?

In November 2012, The European company UniQure, made headlines when its medication Glybera became the first gene therapy approved by regulatory authorities in the Western world. Alexion has developed a post gene translation therapy of providing chaperone molecules to prevent misfolding of gene products. How do these developments affect the research and commercialization of gene and stem cell treatments? What is the real promise of such therapies in treating rare diseases, and what is mere talk?

Dr. Phillips is a Norris Professor of Applied Life Sciences, Faculty Director for the PreMed Program and the Founding Director of the Center for Rare Disease Therapies at the Keck Graduate Institute in Southern California. He was previously a consultant for Merck, Bristol Myers-Squibb and Hoechst. He was Chairman of Physiology at the University of Florida, where he established a modern gene-oriented Department of Physiology and founded the Division of Functional Genomics.

Now currently at KGI, he is pursuing his stem cell therapy studies full time and directs the Center for Rare Disease Therapies, which has many research activities including the search for drugs that can be developed to treat rare diseases. The Center runs workshops with the FDA, projects sponsored by drug companies, and patient advocate groups specializing in rare diseases.

The conference is part of the Drug Discovery Summit 2013, and will run parallel with three other exciting conferences:

• 3rd Epigenetics in Drug Discovery
• 6th Imaging in Drug Discovery and Development
• 7th Drug Design and Medicinal Chemistry

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Professor Ian Phillips to Speak at Orphan Drugs Research & Commercialization Conference May 8-10 in Boston

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today